PMID: 2112162May 1, 1990Paper

Adverse dermatologic reactions to transdermal drug delivery systems

Journal of the American Academy of Dermatology
D J Hogan, H I Maibach

Abstract

Transdermal drug delivery systems are marketed in the United States for four different drugs, and others are in various stages of development. Cutaneous side effects occur frequently with these systems and sometimes necessitate discontinuation of therapy. This article will review these adverse reactions.

References

May 6, 1989·BMJ : British Medical Journal·C R GordonO Spitzer
Mar 1, 1989·Journal of the American Academy of Dermatology·E I McBurneyJ H Collins
Aug 1, 1985·Journal of the American Academy of Dermatology·D J Trozak
May 1, 1987·American Journal of Obstetrics and Gynecology·W H Utian
Mar 1, 1987·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R H GuyD A Bucks
Apr 1, 1985·Contact Dermatitis·C E Grattan, C T Kennedy
Feb 1, 1988·Contact Dermatitis·B K Schwartz, W E Clendenning
Dec 1, 1985·Southern Medical Journal·R G Fischer, M Tyler

❮ Previous
Next ❯

Citations

Dec 1, 1993·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·R E KollochB O Göbel
Dec 1, 1993·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·J BreidthardtL Mehlburger
Dec 8, 2009·Advances in Therapy·Iris AleHoward I Maibach
Sep 2, 1998·Burns : Journal of the International Society for Burn Injuries·N J Bennett
Jan 1, 1997·Clinics in Dermatology·Z Mor, E Caspi
Mar 18, 2004·Contact Dermatitis·Caterina FotiGianni Angelini
Dec 23, 2009·Toxicology and Applied Pharmacology·Mai A Ngo, Howard I Maibach
Feb 23, 2012·Dermatologic Therapy·Charlotte HwaDavid E Cohen
Jan 7, 2015·British Journal of Pharmacology·Michael N PastoreMichael S Roberts
Oct 6, 1998·Journal of Pharmaceutical Sciences·T M MorganB C Finnin
Oct 9, 1999·Journal of Pharmaceutical Sciences·B C Finnin, T M Morgan
Apr 1, 1995·Contact Dermatitis·M CorazzaR Strumia
May 1, 1994·Contact Dermatitis·C M Dwyer, A Forsyth
Feb 28, 2001·Expert Opinion on Investigational Drugs·A GambineriR Pasquali
Jul 2, 2005·Expert Opinion on Investigational Drugs·G Cevc
Aug 1, 1993·Contact Dermatitis·C VincenziF Cusano
Oct 1, 1993·Clinics in Dermatology·G AngeliniM Mastrolonardo
Oct 1, 1993·Contact Dermatitis·G Färm
May 15, 1998·The British Journal of Dermatology·I W LeeS H Lee
Oct 1, 1991·Contact Dermatitis·A J BircherT Rufli
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·A W MeikleN A Mazer
Oct 30, 2020·Frontiers in Pharmacology·Thijs DefraeyeRené M Rossi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Dermatology
E I McBurneyJ H Collins
Burns : Journal of the International Society for Burn Injuries
N J Bennett
© 2021 Meta ULC. All rights reserved